Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes

INTRODUCTION: Type 1 long QT syndrome (LQT1) is a common type of cardiac channelopathy associated with loss-of-function mutations of KCNQ1. Currently there is a lack of drugs that target the defected slowly activating delayed rectifier potassium channel (IKs). With LQT1 patient-specific human induce...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Dongrui, Wei, Heming, Lu, Jun, Huang, Dou, Liu, Zhenfeng, Loh, Li Jun, Islam, Omedul, Liew, Reginald, Shim, Winston, Cook, Stuart A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396080/
https://www.ncbi.nlm.nih.gov/pubmed/25889101
http://dx.doi.org/10.1186/s13287-015-0027-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396080/
https://www.ncbi.nlm.nih.gov/pubmed/25889101
http://dx.doi.org/10.1186/s13287-015-0027-z

Ejemplares similares